Location: Home
  • search
  • go
  • Relate News
  • 6/27/2024Review of Chinese Hospital Drug Sales: Market Trends and Leading TCs
  • 6/27/2024Industry Braces for Biosecure Act Impact (C&EN)
  • 6/26/2024On Efficiency of China's Drug-Related Patent Term Compensation System ...
  • 6/25/2024Fosun to Take Henlius Biotech Private in HK$13.37B Bid
  • 6/25/2024NMPA Solicits Comments on Major Document on Optimizing the Review and ...
  • 6/25/2024Novo Nordisk's Wegovy Approved in China for Weight Loss
  • 6/24/2024Over 75% of Township Health Centers and Community Health Service Cente...
  • 6/21/2024Review of Chinese Pharmaceutical Market Segmentation 2019-2023
  • 6/21/2024Review of Chinese Drug Market Performance of Seven Leading MNCs 2016-2...
  • 6/21/2024Recent Official and Executive Moves
  • 6/20/2024Fosun to Reduce Its Stake in India's Gland Pharma
  • 6/20/2024Biocon Eyes China for Generic Diabetes and Weight-Loss Drug Trials
  • 6/20/2024Cheaper Versions of Blockbuster Obesity Drugs Are Being Created in Ind...
  • 6/19/2024Big Changes to China's BMI System Expected at 3rd Plenum (Pekingnology...
  • 6/19/2024Day One Biopharma Nabs ex-China Rights of MabCare's ADC MTX-13
  • 6/19/2024China Allocates More Urban Medical Resources to Lower-level Healthcare...
  • 6/18/2024China Biopharma Tracker – May 2024 (PharmaDJ)
  • 6/17/2024FDA Halts MediLink-BioNTech's ADC Trial After Three Fatalities
  • 6/14/2024Takeda, Ascentage Enter into Global License Deal for Olverembatinib
  • 6/14/2024Recent Official and Executive Moves
  • 6/14/2024In Depth: How China's Pricing Regime Penalizes Innovative Drugmakers (...
  • 6/13/2024NHSA Solicits Comments on Drafts of the Working Plan and the Applicati...
  • 6/13/2024Ethypharm Expands Its Mesalazine (Etiasa) Portfolio in China 
  • 6/13/2024AbbVie and FutureGen Enter License Deal to Develop Next-Gen Therapy fo...
  • 6/12/2024WuXi PharmaTech Buoyed Amid Uncertainties on BIOSECURE Act's Legislati...
  • 6/12/2024NMPA Issues the Technical Guidelines for Electronic Recording of Blood...
  • 6/12/2024NMPA Issues Revised Blood Product Appendix of Chinese Drug GMP 2010
  • 6/7/2024Novo Nordisk Faces Stiff Generic Competition in China’s Weight-Loss D...
  • 6/7/2024Ipsen and Marengo Announced Second Strategic Partnership to Advance P...
  • 6/7/2024Korean Pharma Booms as U.S. Cuts Ties with Chinese Partners
  • Page:3/333 Total number of articles:9986: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group